The expression of immune checkpoints including programmed cell death protein 1(PD-1), lymphocyte-activation gene 3 (LAG-3), cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) on tumor-infiltrating CD4+ T cells was reduced as well (58). The gene discussed is CTLA4; the disease is neoplasm.